Brief: Timber Pharma Reports Fast Track Designation Granted By FDA For TMB-001 In Severe Subtypes Of Congenital Ichthyosis

Trex Wind-Down

28/04/2022 13:29

April 28 (Reuters) - Timber Pharmaceuticals Inc  TMBR.A :
    * TIMBER PHARMACEUTICALS ANNOUNCES FAST TRACK DESIGNATION
GRANTED
BY FDA FOR TMB-001 IN SEVERE SUBTYPES OF CONGENITAL ICHTHYOSIS
    * TIMBER PHARMACEUTICALS ANNOUNCES FAST TRACK DESIGNATION
GRANTED
BY FDA FOR TMB-001 IN SEVERE SUBTYPES OF CONGENITAL ICHTHYOSIS

Source text for Eikon:  ID:nGNXbLFR7f 
Further company coverage:  TMBR.A 

 ((Reuters.Briefs@thomsonreuters.com;))